Holen Sie sich die Stockscreener-App
1.63
1.87%
0.03
Vorhandelsmarkt:
1.58
-0.05
-3.07%
Schlusskurs vom Vortag:
$1.60
Offen:
$1.53
24-Stunden-Volumen:
1.49M
Relative Volume:
0.30
Marktkapitalisierung:
$5.36M
Einnahmen:
$12.99M
Nettoeinkommen (Verlust:
$-23.72M
KGV:
-0.0168
EPS:
-97.2514
Netto-Cashflow:
$-23.28M
1W Leistung:
-7.39%
1M Leistung:
+10.88%
6M Leistung:
-92.16%
1J Leistung:
-98.44%
1-Tages-Spanne:
$1.53
$1.64
1-Wochen-Bereich:
$1.50
$1.84
52-Wochen-Spanne:
$1.32
$381.10
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Firmenname
Aptevo Therapeutics Inc
Sektor
Branche
Telefon
206-838-0500
Adresse
2401 4TH AVE., SEATTLE, WA
Vergleichen Sie APVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.63 | 22.09M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-11-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-10-05 | Fortgesetzt | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Aktie (APVO) Neueste Nachrichten
Why Aptevo Therapeutics Inc. stock remains a top recommendationJuly 2025 Review & Risk Controlled Swing Trade Alerts - newser.com
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Advanced analytics toolkit walkthrough for Aptevo Therapeutics Inc.July 2025 Price Swings & High Accuracy Buy Signal Tips - newser.com
Why Aptevo Therapeutics Inc. stock appeals to analysts2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
Tools to assess Aptevo Therapeutics Inc.’s risk profileJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - newser.com
Using portfolio simulators with Aptevo Therapeutics Inc. includedEarnings Performance Report & Weekly Stock Performance Updates - newser.com
Why Aptevo Therapeutics Inc. stock remains on watchlists2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
Top chart patterns to watch in Aptevo Therapeutics Inc.2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
How sustainable is Aptevo Therapeutics Inc. stock dividend payoutJuly 2025 Volume & Free Community Supported Trade Ideas - newser.com
How to forecast Aptevo Therapeutics Inc. trends using time seriesJuly 2025 Analyst Calls & Community Trade Idea Sharing Platform - newser.com
Does Aptevo Therapeutics Inc. show high probability of reboundWeekly Market Report & Low Volatility Stock Recommendations - newser.com
Is Aptevo Therapeutics Inc. (AP81) stock inflation resilientWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
Relative strength of Aptevo Therapeutics Inc. in sector analysisChart Signals & Stock Timing and Entry Methods - newser.com
What’s the recovery path for long term holders of Aptevo Therapeutics Inc.July 2025 Update & Consistent Return Strategy Ideas - newser.com
Will Aptevo Therapeutics Inc. stock outperform international peers2025 Top Gainers & High Win Rate Trade Tips - newser.com
Why analysts raise outlook for Aptevo Therapeutics Inc. (AP81) stockJuly 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
What MACD signals say about Aptevo Therapeutics Inc.July 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter - ACCESS Newswire
Interim RAINIER results: Aptevo to present Phase 1b/2 AML data at ASH, SITC, BIO-Europe and ROTH this fall - Stock Titan
APVO Stock Soars After Impressive Trial Results - StocksToTrade
APVO Stock Skyrockets: What’s Fueling the Growth? - timothysykes.com
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
Aptevo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:APVO - Benzinga
Will Aptevo Therapeutics Inc. stock recover faster than marketRate Cut & Fast Entry Momentum Alerts - newser.com
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):